News

Thank you for your applications! 

We want to express our gratitude for your interest in our program and for taking the time to submit your applications. We understand the anticipation of awaiting a decision, and we want to assure you that your application is receiving careful consideration by our Recruitment Committee.

Our committee is dedicated to thoroughly reviewing each application to ensure that all candidates receive fair and equitable consideration. We understand the importance of this decision in shaping your academic and professional future, and we are committed to providing a timely and thoughtful response.

At this time, we kindly ask for your patience as we continue our evaluation process. Rest assured, we will notify you of any updates or decisions regarding your application as soon as they become available.

Apply for a PhD before 31 Jan 2024!

Applications for PhD positions are now open!

The recruitment for IgG4-TREAT has officially started on 27.10.2023! 

We are looking for highly motivated and talented PhD students to contribute to groundbreaking research in the field of IgG4-autoimmune diseases. The PhD researchers will have the opportunity to participate in a comprehensive training programme in academic and industry setup.

The consortium invites applications for 10 individual, multidisciplinary research projects aimed to advance our understanding of IgG4-AID. Funding for these projects has been provided by the EU under the competitive MSCA Doctoral Networks 2022 program. The deadline for applications is set for 31/01/2024. The individual projects are set to start between 31/03/2024 and 01/09/2024.

The applicants are required to meet the eligibility criteria of the MSCA Doctoral Networks Program. The successful candidates will receive funding for 36 months (or 48 months if based in the Netherlands) and will become part of a vibrant network of 9 host laboratories with 7 associated partners from 7 European countries.

Join us in advancing the frontiers of IgG4-AID research and making a lasting impact on the field!

Horizon Europe Grant awarded to IgG4-TREAT consortium

We have successfully secured a highly endowed Doctoral Networks grant from the EU's European Research Executive Agency. The project was awarded 2.6 Mio € to foster research into IgG4-autoimmune diseases and allow the training of a new generation of enthusiastic young scientists specialized in IgG4 autoimmity!